1-6 of 6
leukemia, myeloid, chronic-phase
Close
Sort by
Journal Articles

Is there a best TKI for chronic phase CML?

Richard A. Larson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 250–256.
https://doi.org/10.1182/asheducation-2015.1.250
Published: 2015
Journal Articles

Goals for chronic myeloid leukemia TK inhibitor treatment: how little disease is too much?

Michael J. Mauro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 234–239.
https://doi.org/10.1182/asheducation-2014.1.234
Published: 2014
Journal Articles

Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance

Dale Bixby, Moshe Talpaz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 461–476.
https://doi.org/10.1182/asheducation-2009.1.461
Published: 2009
Journal Articles

Chronic Myeloid Leukemia Stem Cells

Catriona H. Jamieson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 436–442.
https://doi.org/10.1182/asheducation-2008.1.436
Published: 2008
Journal Articles

ABL Kinase Inhibitor Therapy for CML: Baseline Assessments and Response Monitoring

Timothy Hughes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 211–218.
https://doi.org/10.1182/asheducation-2006.1.211
Published: 2006
Journal Articles

Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies

Hagop Kantarjian, Junia V. Melo, Sante Tura, Sergio Giralt, Moshe Talpaz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 90–109.
https://doi.org/10.1182/asheducation.V2000.1.90.90
Published: 2000